CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,175,867)	$ (3,782,545)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock issued for consulting services	264,000	115,250
Amortization of deferred stock compensation		192,472
Preferred stock issued for services		2,821,275
Fair value of stock options issued		124,200
Amortization of deferred financing costs	34,229	26,396
Depreciation	1,341	40
Amortization of discount on convertible notes	231,535	103,517
Write off of licensing costs	15,000
Change in fair values of derivative liabilities	(30,347)	(17,038)
Beneficial conversion feature		29,561
Bad debt expense	16,654
Initial derivative liability expense on convertible notes		25,288
Changes in operating assets and liabilities:
Increase in Accounts receivable	(2,711)	(29,822)
Increase in Inventory	(5,489)	(18,545)
Increase in Prepaid assets and other	(117,076)	(3,872)
Increase in Accounts payable and accrued expenses	54,019	74,495
Increase in Deferred compensation	119,829	72,692
Increase in Tenant deposits	75,000
Net cash used in operating activities	(519,883)	(266,636)
Cash flows from investing activities:
Land acquisition costs	(54,053)
Purchase of equipment and furniture	(9,769)	(2,509)
Advances to related party	(89,988)
Investments	(50,000)
Cash payment portion of acquisition	(20,000)
Security deposits paid	(14,700)
Net cash used in investing activities	(238,510)	(2,509)
Cash flows from financing activities:
Payments received on notes receivable issued for convertible debt	400,000
Proceeds from issuance of convertible debt	500,000	157,500
Proceeds from issuance of convertible notes		300,000
Payment of deferred financing costs	(8,000)	(37,000)
Net cash provided by financing activities	892,000	420,500
Net increase in cash and cash equivalents	133,607	151,355
Cash and cash equivalents, beginning	108,766	1,892
Cash and cash equivalents, ending	242,373	153,247
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for income taxes
Schedule of non-cash financing activities:
Conversion of notes payable and interest into common stock	984,291	133,816
Conversion of litigation contingency liability into common stock		46,449
Conversion of deferred compensation into common stock	60,000	100,022
Conversion of accounts payable and accrued expenses into common stock	50,000
Issuance of note payable for land acquistion	85,750
Common stock issued for acquisition	180,000
Cash paid for acquisition	20,000
Total consideration for acquisition	200,000
Allocation of purchase price to inventory	(7,151)
Allocation of purchase price to goodwill	(192,849)
Total acquisition costs